Skip to main content
. 2024 Feb 8;29(6):2400046. doi: 10.2807/1560-7917.ES.2024.29.6.2400046

Table 1. Nirsevimab immunisation coverage and infant hospitalisations with lower respiratory tract infections by hospital, three regions in Spain, October 2023–January 2024 (n = 166 hospitalisations).

Hospitals by region End of data collection perioda Infants < 9 months of age (n) Population-based immunisation coverage (%)b LRTI (n) RSV-LRTI (n) RSV-LRTI immunised (%) Negative RSV-LRTI (n) Negative RSV-LRTI immunised (%) LRTI per 1,000 infants RSV-LRTI per 1,000 infants
Valencia 7,191 89.8 52 36 72.2 16 81.3 7.2 5.0
Hospital General Universitario de Castellón 31 Dec 2023 1,387 87.5 12 9 33.3 3 100.0 8.7 6.5
Hospital Universitari Politecnic La Fe 10 Jan 2024 2,144 93.6 13 9 33.3 4 75.0 6.1 4.2
Consorcio Hospital General Universitario Valencia 6 Jan 2024 1,621 91.9 12 11 9.1 1 100.0 7.4 6.8
Hospital Universitario Dr Peset 10 Jan 2024 1,19 91.0 9 4 100.0 5 80.0 7.6 3.4
Hospital de la Marina Baixa de la Vila Joiosa 31 Dec 2023 849 78.7 6 3 66.7 3 66.7 7.1 3.5
Murcia 7,449 88.9 107 52 50.0 55 83.6 14.4 7.0
Hospital Rafael Méndez 31 Dec 2023 1,263 89.6 8 3 66.7 5 80.0 6.3 2.4
Hospital General Universitario Santa Lucía 31 Dec 2023 1,555 88.6 39 20 60.0 19 94.7 25.1 12.9
Hospital Clínico Universitario Virgen de la Arrixacac 8 Jan 2024 4,631 88.8 60 29 41.4 31 77.4 13..0 6.3
Valladolid
Hospital Clínico Valladolid 31 Dec 2023 1,036 98.6 7 7 57.1 0 0 6.8 6.8

LRTI: lower respiratory tract infections; RSV: respiratory syncytial virus.

a Start of data collection date was 1 October 2023.

b Immunisation coverage data in Valencia are up to 12 Jan 2024, in Murcia up to 5 Jan 2024, in Valladolid up to 15 Jan 2024.

c At Hospital Clínico Universitario Virgen de la Arrixaca, 11 RSV-LRTI cases were confirmed by antigen testing. The remaining cases in all hospitals were confirmed by PCR.